Fig. 9

SPHK1 facilitates glioma progress by the JAK2/STAT3 pathway. (A–B) The JAK2/STAT3 pathway inhibitor AG490 reverses the overactivation of glioma cell migration ability due to SPHK1 overexpression. (C) AG490 reversed the abnormal elevation of p-JAK2/JAK2 and p-STAT3/STAT3 induced by SPHK1 overexpression. The experiment was performed thrice, and the results are presented as mean and standard deviation. Statistical significance was determined at p < 0.05.